Ono Pharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Ono Pharmaceutical Co., Ltd. - overview
Established
1717
Location
-, Osaka, Japan
Primary Industry
Pharmaceuticals
About
Established in 1717 and based in Osaka, Japan, Ono Pharmaceutical Co. , Ltd. operates as a pharmaceutical company that researches, develops, and sells pharmaceuticals and diagnostic reagents. In April 2024, the firm agreed to fully acquire Deciphera Pharmaceuticals, LLC from Brightstar Associates LLC, BlackRock, Deerfield Management, and Redmile Group for USD 2.
4 billion at USD 25. 60 per share. The firm is registered in the Tokyo Stock Exchange Prime Market bearing the ticker symbol TYO: 4528. The company offers pharmaceuticals and diagnostic reagents, specializing in prescription pharmaceuticals in the areas of oncology, immunology, neurology, and many others.
The product range of the firm includes injectable drugs, oral medication, and patches for the treatment of multiple myeloma, cancer, nausea, and vomiting associated with anticancer drugs, joint function-improving agents, osteoporosis treatment, etc. The April 2024 acquisition may reinforce the pipeline of Ono Pharmaceutical Co. , Ltd. and accelerate its global development, as well as realize direct sales in the US and Europe.
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
https://www.ono-pharma.com/en
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.